These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 17717366

  • 1. Challenges of implementing human papillomavirus (HPV) vaccination policy.
    Raffle AE.
    BMJ; 2007 Aug 25; 335(7616):375-7. PubMed ID: 17717366
    [Abstract] [Full Text] [Related]

  • 2. The economic impact of HPV vaccines: not just cervical cancer.
    Myers ER.
    Am J Obstet Gynecol; 2008 May 25; 198(5):487-8. PubMed ID: 18455522
    [No Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
    Novaes HM, de Soárez PC, Silva GA, Ayres A, Itria A, Rama CH, Sartori AM, Clark AD, Resch S.
    Vaccine; 2015 May 07; 33 Suppl 1():A135-42. PubMed ID: 25919154
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A novel method to value real options in health care: the case of a multicohort human papillomavirus vaccination strategy.
    Favato G, Baio G, Capone A, Marcellusi A, Saverio Mennini F.
    Clin Ther; 2013 Jul 07; 35(7):904-14. PubMed ID: 23806328
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness analysis: an essential tool to inform public health policy in cervical cancer prevention.
    Franco EL, Drummond MF.
    Vaccine; 2008 Sep 15; 26 Suppl 5():F1-2. PubMed ID: 18992378
    [No Abstract] [Full Text] [Related]

  • 9. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P, Jit M.
    Sex Health; 2010 Sep 15; 7(3):352-8. PubMed ID: 20719227
    [Abstract] [Full Text] [Related]

  • 10. Global human papillomavirus vaccination: can it be cost-effective?
    Crosbie EJ.
    BJOG; 2012 Jan 15; 119(2):125-8. PubMed ID: 22168760
    [No Abstract] [Full Text] [Related]

  • 11. Human papillomavirus vaccination: expected impacts and unresolved issues.
    Dempsey AF, Freed GL.
    J Pediatr; 2008 Mar 15; 152(3):305-9. PubMed ID: 18280831
    [No Abstract] [Full Text] [Related]

  • 12. Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted.
    Franco EL.
    BMJ; 2007 Aug 25; 335(7616):378-9. PubMed ID: 17717367
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Just implementation of human papillomavirus vaccination.
    Malmqvist E, Natunen K, Lehtinen M, Helgesson G.
    J Med Ethics; 2012 Apr 25; 38(4):247-9. PubMed ID: 22138726
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V, Murtagh J.
    Issues Emerg Health Technol; 2007 Dec 25; (109):1-8. PubMed ID: 18062141
    [Abstract] [Full Text] [Related]

  • 16. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D, Kravitz-Wirtz N, Breen N, Tiro JA, Tsui J.
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb 25; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of human papilloma virus vaccination in Iceland.
    Oddsson K, Johannsson J, Asgeirsdottir TL, Gudnason T.
    Acta Obstet Gynecol Scand; 2009 Feb 25; 88(12):1411-6. PubMed ID: 19900074
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HPV vaccination in France: uptake, costs and issues for the National Health Insurance.
    Fagot JP, Boutrelle A, Ricordeau P, Weill A, Allemand H.
    Vaccine; 2011 Apr 27; 29(19):3610-6. PubMed ID: 21382486
    [Abstract] [Full Text] [Related]

  • 20. Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy.
    Kim JJ, Kobus KE, Diaz M, O'Shea M, Van Minh H, Goldie SJ.
    Vaccine; 2008 Jul 29; 26(32):4015-24. PubMed ID: 18602731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.